GG
TRAW icon

Golden Green’s Traws Pharma TRAW Stock Holding History

Golden Green’s Portfolio TRAW Stock Details TRAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-32
Closed -$6K – 197
2020
Q4 		$6K Buy
+32
New +$3.71K 0.01% 128

Other funds holding TRAW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

Golden Green's TRAW Position: Q1 2021 in Review

Golden Green sold out of Traws Pharma (TRAW) in Q1 2021, closing a stake of 32 shares — an estimated $6K sold.

Golden Green first reported a position in TRAW in Q4 2020 and held it in 1 quarter. The position peaked at $6K in Q4 2020. 56 funds tracked by Wall St. Rank hold TRAW as of Q1 2021.

  • Golden Green reported no remaining Traws Pharma position as of Q1 2021 after selling out during the quarter.
  • Golden Green sold 32 Traws Pharma shares in Q1 2021, an estimated $6K.
  • Golden Green first reported a position in Traws Pharma in Q4 2020 and held it in 1 quarter.
  • Golden Green's Traws Pharma position peaked at $6K in Q4 2020.
  • 56 funds tracked by Wall St. Rank held Traws Pharma as of Q1 2021.

Based on Golden Green's 13F filing for Q1 2021, filed 13 Apr 2021.